Diana Isaacs

4 days ago | hcplive.com | Diana Isaacs |Natalie Bellini

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Full results from the SURMOUNT-5 trial show tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide 2.4 mg (Wegovy) in adults with obesity, according to findings published in The New England Journal of Medicine and presented at the 32nd European Congress on Obesity.

1 week ago | hcplive.com | Diana Isaacs |Natalie Bellini

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! 00:00:30 Dexcom G7 15-Day Sensor Approval 00:02:11 Challenges with Sensor Lifespan 00:06:00 Education and Replacement Process 00:09:27 Accuracy and FDA Approval Details 00:11:37 Libre's New Mobile App 00:16:55 Integration with Gluco 00:19:41 Medtronic's Simplera Sync Approval 00:23:03 Future Collaborations and Algorithms 00:28:05 Final Thoughts and Wrap-Up In this episode of Diabetes Dialogue: Technology,...

1 week ago | t1dexchange.org | Diana Isaacs

“I wish someone had talked to me about the changes to expect during menopause” is a common concern I hear from people living with diabetes. While robust research is lacking in this area, we do know people who live with type 1 diabetes (T1D) and menstruate experience glucose changes surrounding their cycle — and during perimenopause, menopause, and postmenopausal times in their lives — likely, in part, from fluctuating hormone levels.

2 weeks ago | hcplive.com | Natalie Bellini |Diana Isaacs

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! 00:00:01 Introduction and Participant Backgrounds 00:01:18 Overview of MASH and Insulin Resistance 00:03:28 Phase 2 and Phase 3 Trials of Semaglutide 00:07:23 Significant Findings and Clinical Implications 00:09:44 Challenges and Future Directions 00:14:50 Mechanism of Action and Weight Loss 00:17:39 Data on Weight Loss and Liver Improvement 00:20:42 Potential for FDA Approval and Future Studies 00:25:04...

2 weeks ago | hcplive.com | Diana Isaacs |Natalie Bellini

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! 00:00:01 Catalyst Trial Overview and Introduction 00:01:37 Patient Criteria and Initial Findings 00:04:18 Implications and Next Steps 00:05:23 Adrenal Imaging and Cardiac Disorders 00:07:22 Clinical Implications and Future Research 00:09:13 Demographic Differences and Future Directions In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD,...